Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Receivables (2020 - 2025)

Beauty Health (SKIN) has disclosed Receivables for 6 consecutive years, with $22.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables fell 43.47% to $22.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $22.2 million, a 43.47% decrease, with the full-year FY2024 number at $28.6 million, down 58.9% from a year prior.
  • Receivables was $22.2 million for Q3 2025 at Beauty Health, down from $25.0 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $84.0 million in Q3 2022 to a low of $22.2 million in Q3 2025.
  • A 5-year average of $53.6 million and a median of $55.0 million in 2024 define the central range for Receivables.
  • Peak YoY movement for Receivables: soared 150.81% in 2021, then tumbled 61.02% in 2025.
  • Beauty Health's Receivables stood at $47.2 million in 2021, then skyrocketed by 74.71% to $82.5 million in 2022, then decreased by 15.51% to $69.7 million in 2023, then tumbled by 58.9% to $28.6 million in 2024, then decreased by 22.47% to $22.2 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Receivables are $22.2 million (Q3 2025), $25.0 million (Q2 2025), and $23.3 million (Q1 2025).